Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Revenue From Contracts With Customers and Other Revenue (Tables)

v3.23.3
Note 3 - Revenue From Contracts With Customers and Other Revenue (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Sales revenue:

                               

Tc99m tilmanocept - Europe

  $     $ 7,516     $     $ 14,035  
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2023    

2022

   

2023

   

2022

 

Total deferred revenue related to contracts with customers, beginning of period

  $ 700,000     $ 700,000     $ 700,000     $ 700,000  

Deferred revenue related to milestones achieved

                      100,000  

Deferred revenue related to milestones achieved, written off due to contract renegotiations

                      (100,000

)

Total deferred revenue related to contracts with customers, end of period

  $ 700,000     $ 700,000     $ 700,000     $ 700,000